HannaE., HughesG., EliacharI., WanamakerJ., TomfordW.Fungal osteomyelitis of the temporal bone: a review of reported cases. Ear, Nose and Throat Journal1993; 72(8): 532–41.
2.
KerrJ.R.Fungal growth suppression exhibited by Pseudomonas aeruginosa. J Clin Microbiol1993 (in press).
3.
PetrakR., PottageJ., LevinS.Invasive otitis caused by Aspergillus fumigatus in an immunocompromised patient. J Infect Dis1985; 151: 196.
4.
CunninghamM., YuV.L., TunerJ.Necrotizing otitis externa due to aspergillus in an immunocompromised patient. Arch Otolaryngol Head Neck Surg1988; 114: 55406.
5.
MenachofM.R., JacklerR.K.Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryngol Head Neck Sura1990; 102(3): 285–9.
StraussM., FineE.Aspergillus otomastoiditis an acquired immunodeficiency syndrome. Am J Otol1991; 12(1): 49–53.
8.
McGillT.J.Mycotic infection of the temporal bone. Arch Otolaryngol1978; 104: 140–4.
9.
LouisT.III, LockeyM.Blastomycosis of the middle ear cleft. South Med J1974; 67(12): 1489–91.
10.
GussenCanalis R.Mucormycosis of the temporal bone. Ann Otol Rhinol Laryngol1982; 91: 27–32.
11.
ElanderR.P., MabeJ.A., HamillR.H., GormanM.Metabolism of Tryptophans by Pseudomonas aureofaciens. VI. Production of Pyrrolnitrin by selected Pseudomonas species. Applied Microbiology1968; 16(5): 153–8.
12.
ZhouP., MocekU., SieselB., FlossH.G.Biosynthesis of Pyrrolnitrin. Incorporation of 13C, 15N Double Labelled D- and L-Tryptophan. J Basic Microbiol1992; 32(3): 209–14.
13.
ArimaK., ImanakaM., KousakaM., FukutaA., TamuraG.Pyrrolnitrin, a new antibiotic substance produced by Pseudomonas. Agr Biol Chem (Tokyo)1964; 28: 575–6.
14.
UpadhyayR.S., VisintinL., JayaswalR.K.Environmental factors affecting the antagonism of Pseudomonas cepacia against Trichoderma viride. Can J Microbiol1991; 37: 880–4.
15.
JayaswalR.K., FernandezM.A., SchroederRGIIIIsolation and Characterization of a Pseudomonas strain that restricts growth of various phytopathogenic fungi. Appl Env Microbiol1990; 56)4): 1053–8.
16.
ArimaK., ImanakaM., KousakaM., FukutaA., TamuraG.Isolation and Properties of Pyrrolnitrin. J Antibiot1965; 18: 201–4.
17.
GordeeR.S., MatthewsT.R.Evaluation of the in vitro and in vivo Antifungal Activity of Pyrrolnitrin. Antimicrob Agents Chemother1967; 378–87.
18.
GordeeR.S., MatthewsT.R.Systemic Antifungal Activity of Pyrrolnitrin. Appl Microbiol1969; 17(5): 690–4.
19.
LeisingerT., MargraffR.Secondary metabolites of the Fluorescent Pseudomonads. Microbiological Reviews1979; 43(3): 422–42.
20.
EdwardsJEJr.Invasive Candida Infections. N Engl J Med1991; 324(15): 1060–2.
